| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |